Robert Palmisano

ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support.

AMO Development LLC designs, develops and manufactures femtosecond laser technology for use in ophthalmology. It offers Keratoplasty a blade-free laser approach used to incise corneal tissue. The firm's products include metal cone and glass lens for disposable patient interface. The company was founded in 1997 and is headquartered in Irvine, CA.

OraMetrix, Inc. develops 3-D technology solutions for orthodontic care. The firm specializes in the development of SureSmile system, its proprietary technology that allows the use of precision digital tools throughout all phases of the orthodontic treatment process. Its focus areas encompass digital imaging, diagnosis, treatment planning and monitoring, and robotic archwire customization. The company was founded by Friedrich Riemeier and Rohit C. L. Sachdeva in 1998 and is headquartered in Richardson, TX.

Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA.

Entellus Medical, Inc. is a medical technology company, which engages in the design, development, and commercialization of treatment of chronic and recurrent sinusitis in both adult and pediatric patients. The company was founded by Thomas V. Ressemann and Peter Keith in April 2006 and is headquartered in Saint Paul, MN.

LenSx Lasers, Inc. develops computer-controlled and image-guided laser system. The company was founded by Juhasz Tibor, Weinberg Eric and Kurtz M. Ronald in 2008 and is headquartered in Aliso Viejo, CA.

SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston.

Songbird Holdings LLC designs and manufactures hearing devices. Its products include songbird ultra, songbird ultra 2.0 replacement batteries, 2-pack ultra 2.0 right ear assembly and songbird air. The firm offers its products online, as well as through retailers. Songbird makes it as easy as buying a pair of new reading glasses. It provides a strong alternative to traditional hearing aids that can cost thousands of dollars. The company was founded in 2000 by Frederick J. Fritz and is headquartered in Tulsa, OK.

Abbott Medical Optics, Inc. develops and manufactures medical devices and supplies for eye care. Its products include star s4 IR excimer laser, wavescan wavefront system, intralase FS laser, catalys precision laser system, tecnis iTec preloaded delivery system, compact intuitiv system and ultrazyme enzymatic cleaner. The firm also offers customer and technical support, service agreement, practice development and intralase electronic procedure services. The company was founded in 1976 and is headquartered in Santa Ana, CA.

Saluda Medical Pty Ltd. develops and commercializes neuromodulation technology for chronic pain management. The firm offers pain management and clinical services. The company was founded by John Parker in 2013 and is headquartered in Sydney, Australia.

AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.

Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.

Priveterra Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2020 and is headquartered in Fort Lauderdale, FL.

Part of Saluda Medical Pty Ltd., Saluda Medical, Inc. is a private company that provides research and therapy treatments to disruptive neuromodulation problems. The company is based in Bloomington, MN. The company was founded in 2013. The CEO is James F. Schuermann.